MMR, MMRV and Varicella vaccins
Contract number CW2355553
Solicitation number WS4430024899
Contract award date
Expiry date
Contract value CAD 43,505,625.92
Contract details
This contract was awarded to:
Merck Canada Inc.
- Business address
-
16750 Trans-Canada HwyKirkland, Quebec, H9H 4M7CA
- Notice type
- Request for Proposal
- Procurement method
- Competitive – Open Bidding
- Language(s)
-
English,French
- Selection criteria
- Lowest Price
- Region(s) of delivery
-
Canada
Contract duration
The contract will be for a period of 12 month(s), from 2024/04/01 to 2025/03/31.
Total value of contract
This is the total value of this contract, which includes the initial contract value and the sum of all amendments.
CAD 43,505,625.92
Commodity - UNSPSC
- 51000000 - Drugs and Pharmaceutical Products
Trade agreements
-
Canada-Chile Free Trade Agreement (CCFTA)
-
Canada-Colombia Free Trade Agreement
-
Canada-Korea Free Trade Agreement (CKFTA)
-
Canada-European Union Comprehensive Economic and Trade Agreement (CETA)
-
World Trade Organization Agreement on Government Procurement (WTO GPA)
-
Canada-Ukraine Free Trade Agreement (CUFTA)
-
Canadian Free Trade Agreement (CFTA)
-
Canada-Honduras Free Trade Agreement
-
Canada-Panama Free Trade Agreement
-
Canada-UK Trade Continuity Agreement (Canada-UK TCA)
-
Canada-Peru Free Trade Agreement (CPFTA)
-
Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP)
Reason for limited tendering
A contracting officer can use limited tendering for specific reasons outlined in the applicable trade agreements. The reason for this contract is described below:
-
None
Contact information
Contracting organization
- Organization
-
Department of Public Works and Government Services (PSPC)
- Address
-
11 Laurier St, Phase III, Place du PortageGatineau, Quebec, K1A 0S5Canada
- Contracting authority
- Joy, Sharon (SPAC/PSPC)
- Email
- sharon.joy@tpsgc-pwgsc.gc.ca
Buying organization(s)
Related notices
Amendments made to this contract (1) A total of 1 amendments have been made to this contract. Click to collapse
This is a list of the amendments made to contract
CW2355553 that is awarded to Merck Canada Inc..
Amendment number
|
Contract value
|
Award date
|
|---|---|---|
| 001 | CAD 43 505 625.92 | 2024/03/25 |
Tender notices (1) This contract has 1 related tender notices. Click to collapse
|
Title
|
Solicitation Number
|
Publication date
|
Closing date
|
|---|---|---|---|
| RFP MMR, MMRV and Varicella vaccines | WS4430024899 | 2024/02/07 | 2024/02/28 |
Contracts awarded (2) This contract has 2 related award notices. Click to collapse
This is a list of other contracts that were awarded related to solicitation number WS4430024899. Click the link under “More details” to view the contract details.
|
Company name
|
Contract number
|
Amendment date
|
Award date
|
More details |
|---|---|---|---|---|
| Merck Canada Inc. | CW2355553 | 2024/07/30 | 2024/03/25 | Viewthe details of contract CW2355553 for Merck Canada Inc. |
| GlaxoSmithKline Inc. | CW2355560 | Not available | 2024/03/25 | Viewthe details of contract CW2355560 for GlaxoSmithKline Inc. |
Contract history (2) This contract has 2 related contracts. Click to collapse
This is a list of other contracts that were awarded and their amendments. Click the link under “More details” to view the contract details.
|
Company name
|
Contract number
|
Amendment number
|
Award date
|
More details |
|---|---|---|---|---|
| Merck Canada Inc. | CW2355553 | 001 | 2024/03/25 | Viewthe details of contract CW2355553 for Merck Canada Inc. |
| GlaxoSmithKline Inc. | CW2355560 | 000 | 2024/03/25 | Viewthe details of contract CW2355560 for GlaxoSmithKline Inc. |
